NEW YORK (360Dx) – Chembio Diagnostics announced today that preliminary estimates show its fourth quarter 2018 revenues increased by between 22 percent and 27 percent over the prior-year quarter.

For the three months ended Dec. 31, 2018, the firm reported preliminary revenues of between $7.3 million and $7.6 million.

Chembio, which has a focus on infectious disease diagnostics, said its preliminary revenues for 2018 were between $33.1 million and $33.4 million, an increase of about 38 percent to 39 percent compared to the full-year 2017. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Feb
26
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease. 

Mar
19

In this webinar, Dr. Matthew Faron, a pathologist from the Medical College of Wisconsin, will share results of a comparison study of three rapid influenza assays.

 

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.